Skip to main content
IMNM filings

Corporate insider profile

Max Rosett Filing Activity

Latest reported as Chief Financial Officer of Immunome Inc. (IMNM).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,093,800.00
Latest transaction
Jun 15, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 15, 2026Immunome Inc. (IMNM)Chief Financial OfficerSale60,000$18.23$1,093,800